Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Peritoneal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00310076
What this trial is testing

Thalidomide in Treating Patients Who Have Undergone Surgery and Chemotherapy for Cancer That Has Spread Throughout the Abdomen Due to Colorectal Cancer or Appendix Cancer

Who this might be right for
Carcinoma of the AppendixColorectal Cancer
Wake Forest University Health Sciences 29
Not applicableStudy completedNCT06478368
What this trial is testing

Prediction of Occult Peritoneal Metastasis of Locally Advanced Gastric Cancer Using Multimodal Data Based on Artificial Intelligence Combined With Intraoperative Dynamic Video

Who this might be right for
This Study Uses AI and Multimodal Data to Noninvasively Detect Occult Peritoneal Metastasis
Qun Zhao 1,000
Testing effectiveness (Phase 2)Ended earlyNCT00179725
What this trial is testing

Phase I/II Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile of Lenalidomide (Revlimid® CC-5013) With Liposomal Doxorubicin In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma

Who this might be right for
Ovarian Cancer
Celgene Corporation 60
Not applicableWithdrawnNCT02667925
What this trial is testing

Study of the Isotopic Distribution of Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Ovarian Origin

Who this might be right for
Ovarian Cancer
Centre Jean Perrin
Early research (Phase 1)Ended earlyNCT01952249
What this trial is testing

Demcizumab Plus Paclitaxel in Subjects With Platinum Resistant Ovarian

Who this might be right for
Primary Peritoneal Carcinoma
OncoMed Pharmaceuticals, Inc. 20
Not applicableStudy completedNCT03892031
What this trial is testing

Circulatory Function in Laparoscopic Radical Cystectomy for Bladder Cancer

Who this might be right for
Circulatory FunctionLaparoscopic Radical Cystectomy for Bladder Cancer
RenJi Hospital 186
Early research (Phase 1)Study completedNCT00475956
What this trial is testing

Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid Tumours

Who this might be right for
Neoplasms
AstraZeneca 40
Testing effectiveness (Phase 2)Study completedNCT01764802
What this trial is testing

Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer

Who this might be right for
Ovarian SarcomaOvarian Stromal CancerStage I Uterine Sarcoma+59 more
Ohio State University Comprehensive Cancer Center 100
Testing effectiveness (Phase 2)Study completedNCT01989546
What this trial is testing

Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations

Who this might be right for
Advanced Ovarian CancerPrimary Peritoneal CancerAdvanced Breast Cancer+1 more
National Cancer Institute (NCI) 9
Early research (Phase 1)Study completedNCT01220154
What this trial is testing

Study of Intraperitoneal Carboplatin With IV Paclitaxel and Bevacizumab in Untreated Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer+1 more
David O'Malley 9
Not applicableStudy completedNCT01391351
What this trial is testing

Search for Predictors of Therapeutic Response in Ovarian Carcinoma

Who this might be right for
Carcinoma of the OvaryFallopian Tube CancerPeritoneal Serous-type Advanced Stage
Centre Francois Baclesse 107
Early research (Phase 1)Ended earlyNCT00303888
What this trial is testing

Docetaxel With or Without Phenoxodiol in Treating Patients With Recurrent Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Yale University 31
Large-scale testing (Phase 3)Study completedNCT01142622
What this trial is testing

Intraperitoneal Ropivacaine Nebulization for Pain Control After Gynecologic Laparoscopic Surgery

Who this might be right for
Ovarian Cysts
San Gerardo Hospital 140
Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Not applicableActive Not RecruitingNCT04157322
What this trial is testing

Plasma 5hmC Signatures as a Marker of Colorectal / Appendiceal Peritoneal Metastasis

Who this might be right for
Colorectal Cancer Stage IVColorectal Cancer MetastaticColorectal Cancer, Genetics of+1 more
University of Chicago 55
Early research (Phase 1)Active Not RecruitingNCT07118176
What this trial is testing

Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers

Who this might be right for
Anal CarcinomaBladder CarcinomaBreast Carcinoma+31 more
Jonsson Comprehensive Cancer Center 30
Not applicableStudy completedNCT04546373
What this trial is testing

Niraparib as Maintenance Therapy in Patients With Platinum Sensitive Recurrent Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Grupo Español de Investigación en Cáncer de Ovario 316
Testing effectiveness (Phase 2)Study completedNCT01519869
What this trial is testing

Trial of Chemotherapy in Ovarian, Fallopian Tube and Peritoneal Carcinoma

Who this might be right for
Primary Peritoneal CarcinomaOvarian CarcinomaFallopian Tube Carcinoma
Rachel Miller 28
Testing effectiveness (Phase 2)Study completedNCT05041062
What this trial is testing

Immunotherapy Drugs Nivolumab and Ipilimumab in Patients w/Resectable Malignant Peritoneal Mesothelioma

Who this might be right for
MesotheliomaPeritoneal Mesothelioma
University of Chicago 2
Not applicableUnknownNCT05597683
What this trial is testing

Quadratus Lumborum Block After Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy

Who this might be right for
Cytoreductive SurgeryHyperthermic Intra-peritoneal ChemotherapyPeritoneal Cancer
Gangnam Severance Hospital 50
Next Page